These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 9466541)

  • 1. High human immunodeficiency virus type 1 RNA load in the cerebrospinal fluid from patients with lymphocytic meningitis.
    Morris L; Silber E; Sonnenberg P; Eintracht S; Nyoka S; Lyons SF; Saffer D; Koornhof H; Martin DJ
    J Infect Dis; 1998 Feb; 177(2):473-6. PubMed ID: 9466541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased activity of matrix metalloproteinases in the cerebrospinal fluid of patients with HIV-associated neurological diseases.
    Liuzzi GM; Mastroianni CM; Santacroce MP; Fanelli M; D'Agostino C; Vullo V; Riccio P
    J Neurovirol; 2000 Apr; 6(2):156-63. PubMed ID: 10822329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors influencing cerebrospinal fluid and plasma HIV-1 RNA detection rate in patients with and without opportunistic neurological disease during the HAART era.
    Christo PP; Greco DB; Aleixo AW; Livramento JA
    BMC Infect Dis; 2007 Dec; 7():147. PubMed ID: 18096083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between human immunodeficiency virus-associated dementia and viral load in cerebrospinal fluid and brain.
    McArthur JC; McClernon DR; Cronin MF; Nance-Sproson TE; Saah AJ; St Clair M; Lanier ER
    Ann Neurol; 1997 Nov; 42(5):689-98. PubMed ID: 9392567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of human immunodeficiency virus (HIV) type 1 RNA levels in cerebrospinal fluid and viral resistance to zidovudine in children with HIV encephalopathy.
    Sei S; Stewart SK; Farley M; Mueller BU; Lane JR; Robb ML; Brouwers P; Pizzo PA
    J Infect Dis; 1996 Dec; 174(6):1200-6. PubMed ID: 8940209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrathecal synthesis of interleukin-10 (IL-10) in viral and inflammatory diseases of the central nervous system.
    Gallo P; Sivieri S; Rinaldi L; Yan XB; Lolli F; De Rossi A; Tavolato B
    J Neurol Sci; 1994 Oct; 126(1):49-53. PubMed ID: 7836946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrospinal fluid human immunodeficiency virus type 1 (HIV-1) p24 antigen levels in HIV-1-related dementia.
    Royal W; Selnes OA; Concha M; Nance-Sproson TE; McArthur JC
    Ann Neurol; 1994 Jul; 36(1):32-9. PubMed ID: 7912918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimation of virological and immunological parameters in subjects from South India infected with human immunodeficiency virus type 1 clade C and correlation of findings with occurrence of neurological disease.
    Kamat A; Ravi V; Desai A; Satishchandra P; Satish KS; Kumar M
    J Neurovirol; 2009 Jan; 15(1):25-35. PubMed ID: 19031329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrospinal fluid HIV-1 RNA levels in asymptomatic patients with early stage chronic HIV-1 infection: support for the hypothesis of local virus replication.
    García F; Niebla G; Romeu J; Vidal C; Plana M; Ortega M; Ruiz L; Gallart T; Clotet B; Miró JM; Pumarola T; Gatell JM
    AIDS; 1999 Aug; 13(12):1491-6. PubMed ID: 10465072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal fluid viral load, intrathecal immunoactivation, and cerebrospinal fluid monocytic cell count in HIV-1 infection.
    Gisslén M; Fuchs D; Svennerholm B; Hagberg L
    J Acquir Immune Defic Syndr; 1999 Aug; 21(4):271-6. PubMed ID: 10428104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrospinal fluid mononuclear cell counts influence CSF HIV-1 RNA levels.
    Martin C; Albert J; Hansson P; Pehrsson P; Link H; Sönnerborg A
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Mar; 17(3):214-9. PubMed ID: 9495220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1 RNA levels in the cerebrospinal fluid may increase owing to damage to the blood-brain barrier.
    Burger DM; Boucher CA; Meenhorst PL; Kraayeveld CL; Portegies P; Mulder JW; Hoetelmans RM; Beijnen JH
    Antivir Ther; 1997 Apr; 2(2):113-7. PubMed ID: 11322275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrathecal synthesis of soluble class I antigens (sHLA) in patients with HIV infection and tuberculous meningitis.
    Alvarez-Cermeño JC; Varela JM; Villar LM; Casado C; Dominguez M; Roy G; Bootello A; Gonzalez-Porque P
    J Neurol Sci; 1990 Dec; 100(1-2):152-4. PubMed ID: 2089132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-17 mediated differences in the pathogenesis of HIV-1-associated tuberculous and cryptococcal meningitis.
    Marais S; Meintjes G; Lesosky M; Wilkinson KA; Wilkinson RJ
    AIDS; 2016 Jan; 30(3):395-404. PubMed ID: 26765934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary and opportunistic pathogens associated with meningitis in adults in Bangui, Central African Republic, in relation to human immunodeficiency virus serostatus.
    Békondi C; Bernede C; Passone N; Minssart P; Kamalo C; Mbolidi D; Germani Y
    Int J Infect Dis; 2006 Sep; 10(5):387-95. PubMed ID: 16473538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levels of human immunodeficiency virus type 1 RNA in cerebrospinal fluid correlate with AIDS dementia stage.
    Brew BJ; Pemberton L; Cunningham P; Law MG
    J Infect Dis; 1997 Apr; 175(4):963-6. PubMed ID: 9086160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of HIV RNA levels in intraocular and cerebrospinal fluids in patients with AIDS-related cryptococcosis.
    Peng CH; Chen SJ; Ho CK; Ku HH; Lin HW; Chen SS; Wu CC; Chi CW; Hsu WM; Chiou SH
    Ophthalmologica; 2005; 219(2):101-6. PubMed ID: 15802935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of spinal fluid beta 2-microglobulin levels with CD4+ T cell count, in vitro T helper cell function, and spinal fluid IgG parameters in 163 neurologically normal adults infected with the human immunodeficiency virus type 1.
    Lucey DR; McGuire SA; Clerici M; Hall K; Benton J; Butzin CA; Ward WW; Shearer G; Boswell RN; Hendrix CW
    J Infect Dis; 1991 May; 163(5):971-5. PubMed ID: 1673466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect on human immunodeficiency virus type 1 RNA levels in cerebrospinal fluid after initiation of zidovudine or didanosine.
    Gisslén M; Norkrans G; Svennerholm B; Hagberg L
    J Infect Dis; 1997 Feb; 175(2):434-7. PubMed ID: 9203666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in human immunodeficiency virus-1C viral load and drug resistance mutation between plasma and cerebrospinal fluid in patients with human immunodeficiency virus-associated cryptococcal meningitis in Botswana.
    Kelentse N; Moyo S; Mogwele M; Lechiile K; Moraka NO; Maruapula D; Seatla KK; Esele L; Molebatsi K; Leeme TB; Lawrence DS; Musonda R; Kasvosve I; Harrison TS; Jarvis JN; Gaseitsiwe S
    Medicine (Baltimore); 2020 Oct; 99(41):e22606. PubMed ID: 33031315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.